C71T
CANCELLED SECTION 71
10/07/2026
Voltar para busca
Dado oficial do USPTO
NI-TECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
04/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
26/09/2018
Data de registro
24/12/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/07/2026
Última transação
04/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Fukushima 960-85, JP
Examinador
VAGHANI, MAYUR C
Unidade examinadora
O30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NITTO BOSEKI, CO., LTD.
Representantes
M. Scott Alprin Alprin Law Offices, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
In vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; diagnostic test reagents for medical purposes; biochemical preparations for medical purposes for hyperphosphatemia; biological reagents for medical purposes; biological preparations for medical purposes for cancer or autoimmune disease; chemical reagents for medical purposes; reagents for medical purposes; clinical diagnostic reagents for medical purposes; diagnostic agentspreparations and substances for infectiousparasitic diseasescancerneoplasmsdiseases of the blood or blood-forming organscertain disorders involving the immune mechanismendocrine diseasesnutritional and metabolic diseasesdiseases of the nervous systemdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary systempregnancychildbirththe puerperiumcertain conditions originating in the perinatal periodcongenital malformationsdeformations or chromosomal abnormalities for medical purposes; chemical preparations for medical purposes for hyperphosphatemia; antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; medical diagnostic test strips for blood analysisurine analysissaliva analysisstool analysissputum analysispharyngeal swab analysis; medicated serums for diagnostic test reagents
Classe 10
Medical apparatus and instruments for diagnosing or treating respiratory conditionsthermometerelectrocardiographheart rate monitorsphygmomanometer or circulatory monitoring device; diagnostic apparatus for medical purposes for testing the amounts or types of DNARNA or proteinsthe number of cells in clinical specimen sampled from bloodurinesalivastoolsputumswabcellstissues or organisms; blood testing apparatus; apparatus for clinical diagnosis for testing the amounts or types of DNARNA or proteinsthe number of cells in clinical specimen sampled from bloodurinesalivastoolsputumswabcellstissues or organisms; analyzersapparatus for blood analysisurine analysissaliva analysisstool analysissputum analysisswab analysis for pathogenic microorganisms identification for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/12/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/02/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/04/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/04/2020
FIMP
FINAL DISPOSITION PROCESSED
02/04/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
24/12/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/10/2019
PUBO
PUBLISHED FOR OPPOSITION
08/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
05/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/09/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/09/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
05/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
05/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/08/2019
ALIE
ASSIGNED TO LIE
14/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2019
RFNT
REFUSAL PROCESSED BY IB
02/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/02/2019
RFRR
REFUSAL PROCESSED BY MPU
08/02/2019
MAFR
APPLICATION FILING RECEIPT MAILED
29/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/01/2019
CNRT
NON-FINAL ACTION WRITTEN
25/01/2019
DOCK
ASSIGNED TO EXAMINER
25/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/01/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NI-TECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.